ACTR10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.421600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.501400E-01
Normal-vs-Stage2
9.875200E-01
Normal-vs-Stage3
2.904400E-01
Normal-vs-Stage4
9.735200E-01
Stage1-vs-Stage2
8.514400E-01
Stage1-vs-Stage3
1.620170E-01
Stage1-vs-Stage4
9.577400E-01
Stage2-vs-Stage3
1.084010E-01
Stage2-vs-Stage4
9.572600E-01
Stage3-vs-Stage4
4.456600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.143200E-01
Normal-vs-AfricanAmerican
8.034800E-01
Normal-vs-Asian
5.402400E-01
Caucasian-vs-AfricanAmerican
5.631400E-01
Caucasian-vs-Asian
1.647050E-01
AfricanAmerican-vs-Asian
7.055400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.348400E-01
Normal-vs-Female
9.456600E-01
Male-vs-Female
9.366200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.064800E-01
Normal-vs-Age(41-60Yrs)
5.565000E-01
Normal-vs-Age(61-80Yrs)
8.673200E-01
Normal-vs-Age(81-100Yrs)
9.840000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.364000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.926600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.327800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.147970E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.643600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.808600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.023800E-01
Normal-vs-Daily Drinker
9.534600E-01
Normal-vs-Weekly Drinker
4.604200E-01
Normal-vs-Occasional Drinker
4.316200E-01
Normal-vs-Social Drinker
9.101600E-01
Non Drinker-vs-Daily Drinker
4.932800E-01
Non Drinker-vs-Weekly Drinker
4.934600E-01
Non Drinker-vs-Occasional Drinker
1.280210E-02
Non Drinker-vs-Social Drinker
3.689000E-01
Daily Drinker-vs-Weekly Drinker
2.239200E-01
Daily Drinker-vs-Occasional Drinker
6.767700E-02
Daily Drinker-vs-Social Drinker
7.409000E-01
Weekly Drinker-vs-Occasional Drinker
1.559520E-02
Weekly Drinker-vs-Social Drinker
2.165000E-01
Occasional Drinker-vs-Social Drinker
2.242400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.325000E-01
Normal-vs-Grade 2
5.811000E-01
Normal-vs-Grade 3
5.760400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.903600E-01
Grade 1-vs-Grade 3
8.652000E-01
Grade 1-vs-Grade 4
2.325000E-01
Grade 2-vs-Grade 3
8.837600E-01
Grade 2-vs-Grade 4
5.811000E-01
Grade 3-vs-Grade 4
5.760400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.911400E-01
Normal-vs-NonDiabetic
9.341400E-01
Diabetic-vs-NonDiabetic
4.900400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.699400E-01
Normal-vs-NoPancreatitis
9.085600E-01
Pancreatitis-vs-NoPancreatitis
9.805900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.954400E-01
Normal-vs-N1
9.934200E-01
N0-vs-N1
6.428800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.449400E-01
Normal-vs-TP53-NonMutant
9.794600E-01
TP53-Mutant-vs-TP53-NonMutant
2.699400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
